Venture capital firm Syncona Partners has committed to invest up to £34m in a £35m series-A funding round for newly launched UK-headquartered cell therapy company Quell Therapeutics.
Stake being sold amounts to around 1.3% of Getir's total share capital
CVC is to acquire a minority shareholding in the new venture for EUR 2.7bn
LDC backed the management buyout of Pelsis from US-based GP Wind Point Partners in 2017
Bain-led consortium that includes local player Sener is poised to take over ITP with a EUR 1.6bn bid